During the past decade, CH de Montbrison conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH de Montbrison" #1 sponsor was "Centre Hospitalier Universitaire de Saint Etienne" with 5 trials, followed by "Centre Hospitalier Emile Roux" with 1 trials sponsored, "Centre Hospitalier Intercommunal Creteil" with 1 trials sponsored, "Institut de Cancérologie de la Loire" with 1 trials sponsored and "University Hospital, Grenoble" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH de Montbrison" #1 collaborator was "Association Clinique Thérapeutique Infantile du val de Marne" with 1 trials as a collaborator, "Floralis" with 1 trials as a collaborator, "Francophone Pediatric Resuscitation and Emergency Group (GFRUP)" with 1 trials as a collaborator, "GPIP" with 1 trials as a collaborator and "Ministry of Health, France" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "CH de Montbrison" are "Atrial Fibrillation" (2 trials), "Fibromyalgia" (2 trials), "Acute Coronary Syndrome" (1 trials), "COVID-19" (1 trials) and "Cancer" (1 trials). Many other conditions were trialed in "CH de Montbrison" in a lesser frequency.

Most popular intervention types in "CH de Montbrison" are "Other" (5 trials) and "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials), "Advice and recommendations of physical activity at home" (1 trials), "Antiplatelet therapy (AP)" (1 trials), "Full-dose anticoagulant therapy (AC)" (1 trials) and "ambulatory surgery description" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH de Montbrison" are 10 trials for "All" genders.

Currently, there are NaN active trials in "CH de Montbrison". 1 are not yet recruiting, 3 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in CH de Montbrison, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in CH de Montbrison, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".